APA (7th ed.) Citation

DR, K., KD, P., MC, S., LN, H., JR, C., & KS, M. (2021). Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide. The Journal of biological chemistry, 296, 100807. https://doi.org/10.1016/j.jbc.2021.100807

Chicago Style (17th ed.) Citation

DR, Kamm, Pyles KD, Sharpe MC, Healy LN, Colca JR, and McCommis KS. "Novel Insulin Sensitizer MSDC-0602K Improves Insulinemia and Fatty Liver Disease in Mice, Alone and in Combination With liraglutide." The Journal of Biological Chemistry 296 (2021): 100807. https://doi.org/10.1016/j.jbc.2021.100807.

MLA (9th ed.) Citation

DR, Kamm, et al. "Novel Insulin Sensitizer MSDC-0602K Improves Insulinemia and Fatty Liver Disease in Mice, Alone and in Combination With liraglutide." The Journal of Biological Chemistry, vol. 296, 2021, p. 100807, https://doi.org/10.1016/j.jbc.2021.100807.